Ms Sandra Siegel, MA, CCC-A | |
880 W Central Rd Ste 4300, Arlington Heights, IL 60005-2381 | |
(847) 392-2250 | |
(847) 392-2204 |
Full Name | Ms Sandra Siegel |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 32 Years |
Location | 880 W Central Rd Ste 4300, Arlington Heights, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205960333 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northwest Speech And Hearing Center Ltd | 5890681712 | 6 |
News Archive
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
Kai Humphrey, 9, has been learning from home for more than a year. He badly misses his Washington, D.C., elementary school, along with his friends and the bustle of the classroom.
Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Provider Name | Northwest Speech And Hearing Center Ltd |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1215060314 PECOS PAC ID: 5890681712 Enrollment ID: O20040226000303 |
News Archive
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
Kai Humphrey, 9, has been learning from home for more than a year. He badly misses his Washington, D.C., elementary school, along with his friends and the bustle of the classroom.
Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Sandra Siegel, MA, CCC-A 880 W Central Rd Ste 4300, Arlington Heights, IL 60005-2381 Ph: (847) 392-2250 | Ms Sandra Siegel, MA, CCC-A 880 W Central Rd Ste 4300, Arlington Heights, IL 60005-2381 Ph: (847) 392-2250 |
News Archive
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
Kai Humphrey, 9, has been learning from home for more than a year. He badly misses his Washington, D.C., elementary school, along with his friends and the bustle of the classroom.
Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Ryland Gallagher, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 | |
Dr. Mary Catherine Chisholm, AU.D., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 880 W Central Rd Ste 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 Fax: 847-392-2204 | |
Northwest Speech And Hearing Center Ltd. Audiologist Medicare: Medicare Enrolled Practice Location: 880 W Central Rd Ste 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 Fax: 847-392-2204 | |
Dr. Lauren E Moss, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd, Suite 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 | |
Ms. Michelle R. Petrak, PH.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 Fax: 847-392-2204 | |
Kimberley A Franczyk, AUD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 4300, Arlington Heights, IL 60005 Phone: 847-392-2250 Fax: 847-392-2204 |